1.2million women a year miss cervical cancer screening
Nearly a third of women ignored smear test invitations last year, figures show. Health bosses urged GPs to provide more convenient appointments in a bid increase uptake.
International Journal of Cancer, EarlyView.
CONCLUSIONS: Primary prevention and early detection are key interventions for reducing disparities in cervical cancer incidence and treatment. Community outreach efforts play an important role in reducing inequities in cancer among high-risk groups. The educational intervention utilized in this study was successful in improving knowledge about HPV and cervical cancer. PMID: 29605043 [PubMed - in process]
Abstract Screening in women has decreased the incidence and mortality of cervical cancer. Precancerous cervical lesions (cervical intraepithelial neoplasias) and cervical carcinomas are strongly associated with sexually-transmitted high-risk human papillomavirus (HPV) infection, which causes more than 99% of cervical cancers. Screening methods include cytology (Papanicolaou test) and HPV testing, alone or in combination. The American Academy of Family Physicians and the U.S. Preventive Services Task Force recommend starting screening in immunocompetent, asymptomatic women at 21 years of age. Women 21 to 29 years o...
Abstract Human papillomavirus infection is the precursor for the development of cervical cancer and is detectable in 99.7% of squamous cell carcinoma and adenocarcinoma cases. Early detection of precancerous lesions with Papanicolaou testing remains the primary mechanism for cancer prevention. Once cervical cancer is diagnosed, treatment may involve surgery, radiation therapy, chemotherapy, or a combination. The choice of therapy depends on the stage of disease, lymph node involvement, patient comorbidities, and risk factors for recurrence. Early-stage, microinvasive disease may be treated with surgery alone if ma...
Cancer Science, EarlyView.
This article is protected by copyright. All rights reserved. PMID: 29602167 [PubMed - as supplied by publisher]
Conclusions: The results show that applying an educational intervention based on PMT might help prevent cervical cancer and improve regular Pap smear testing. PMID: 29582631 [PubMed - in process]
AbstractBackgroundEthnic minority women are at increased risk of cervical cancer. Self-sampling for high-risk human papillomavirus (HPV) is a promising approach to increase cervical screening among hard-to-reach populations.ObjectiveTo compare a community health worker (CHW)-led HPV self-sampling intervention with standard cervical cancer screening approaches.DesignA 26-week single-blind randomized pragmatic clinical trial.ParticipantsFrom October 6, 2011 to July 7, 2014, a total of 601 Black, Haitian, and Hispanic women aged 30 –65 years in need of cervical cancer screening were recruited, 479 of whom completed...
Journal of Women's Health, Ahead of Print.
CONCLUSION: The Xpert HPV test is convenient to use on cervical cell samples collected for Pap smear specimens in BD SurePath preservative fluid within an hour and is a viable alternative to the HC2 High-Risk HPV DNA Test for HPV testing. PMID: 29580367 [PubMed - as supplied by publisher]